New hope for kids with MS: ocrelizumab trial aims to tame relapses
NCT ID NCT04075266
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times
Summary
This study tests the safety and best dose of ocrelizumab in children and teens (ages 10 to 18) with relapsing-remitting multiple sclerosis. Over 2 years, researchers will monitor how the drug works in the body and its effects on immune cells. The goal is to find the right dose for a larger future study in young people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AOU Policlinico V. Emanuele - P.O G. Rodolico
Catania, Sicily, 95123, Italy
-
Azienda Ospedaliera Sant'Andrea
Rome, Lazio, 00189, Italy
-
Boston Childrens Hospital
Boston, Massachusetts, 02115, United States
-
Childrens National Health Center
Washington D.C., District of Columbia, 20010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Dzieci?cy Szpital Kliniczny im. Józefa Polikarpa Brudzi?skiego
Warsaw, 02-091, Poland
-
Instytut Pomnik Centrum Zdrowia Dziecka
Warsaw, 04-730, Poland
-
Ospedale Pediatrico Bambino Gesù
Rome, Lazio, 00165, Italy
-
University of Colorado Denver Childrens Hospital Rocky Mountain MS Center
Aurora, Colorado, 80045, United States
-
Uniwersytecki Szpital Kliniczny w Poznaniu
Późna, 60-355, Poland
-
Uniwersyteckie Centrum Kliniczne
Gda?sk, 80-952, Poland
-
Washington Universtiy school of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.